AstraZeneca’s purpose is to push the boundaries of science to deliver life-changing medicines. We want to be valued as a source of great medicines and trusted as a company that delivers business success sustainably.
Areas of focus
In 2013, we announced a revised business strategy and our Senior Executive Team (SET) endorsed a focused approach to sustainability for the company that is aligned to, and supports, the delivery of our business strategy. Our two areas of special focus, 1) access to healthcare and 2) environmental sustainability, were identified as we believe we have both the capability and responsibility to implement activities that accelerate our business strategy while delivering wider benefits to society and the environment.
Good governance is crucial to ensuring we are well managed, can deliver our strategic priorities and meet stakeholder expectations. Our sustainability framework is the vehicle for managing commitments that are agreed across the Group, taking account of external stakeholder insights and internal reputational risk assessment.
Access to healthcare
We are committed to increasing access to healthcare for underserved patient populations in a sustainable way. Our goal is always to improve health for patients and to add value for our stakeholders and our business.
We are committed to environmental stewardship across the product life cycle, from discovery and development, through to manufacturing, marketing, use and ultimately disposal. We are also committed to minimising the environmental impact of our operations by reducing the carbon footprint and natural resource demands of our own and our suppliers’ business activities.
In addition to our special focus areas, our sustainable business commitments include:
Ethical business practices
We are committed to delivering consistently high ethical standards of sales and marketing practices and to integrating ethical standards into our procurement activities and decisions worldwide. We also aim to make a positive contribution to our local communities, wherever we are located in the world.
The safety of the patients who take our medicines is of fundamental importance to us. We set high standards of ethical practice across all aspects of our research activity worldwide, from clinical trials to our research with animals. We also work to ensure that we are aware of any risks to patient safety such as side effects of cases of product counterfeiting
Be a great place to work
To achieve our strategic priorities we need to acquire, retain and develop a talented workforce. We are building an inclusive, open and trusting organisation that embraces the skills, knowledge and unique ability of our employees. In addition to keeping our employees safe and healthy, we are committed to respecting and embedding international human rights in our operations.